Yalmo

Company Overview

Snapshot

Founded in April 2021 by Roman Karasik, Yalmo operates with 1–10 employees. The company secured a Pre-Seed funding round in September 2021 from the Israel Innovation Authority.

Business overview

Yalmo is a Health Tech & Life Sciences company that develops a personalized behavior-management AI platform for children with Autism Spectrum Disorder (ASD). The system monitors children's activities and provides solutions based on advanced data analysis to improve daily routines and prevent outbursts. Yalmo's technology aims to help families and caregivers understand challenging behaviors, adjust daily routines, and create a more secure environment, operating within the Digital Healthcare sector with a focus on Patient Remote Monitoring.

Strategic signal

Yalmo ceased operations in December 2024, indicating a significant strategic shift and the conclusion of its efforts in developing AI-powered solutions for children with Autism Spectrum Disorder. This event signals to investors and innovation teams the inherent risks and challenges within the specialized health tech market, particularly for early-stage ventures targeting niche patient populations.

Company Intelligence Q&A

What is Yalmo's primary focus?

Yalmo focuses on developing an AI system for children with Autism Spectrum Disorder, aiming to improve the quality of life for affected families through personalized behavior management.

When was Yalmo founded?

Yalmo was founded in April 2021.

Who is the founder of Yalmo?

Roman Karasik is the co-founder and CEO of Yalmo.

What was a key funding milestone for Yalmo?

In September 2021, Yalmo secured Pre-Seed funding from the Israel Innovation Authority.

What is the current operational status of Yalmo?

Yalmo ceased to operate in December 2024.